IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Develops T cell immunotherapies and vaccines for cancers, COVID-19, and other diseases.
Industry: Health Care
Latest Trade: $2.34 0.00 (0.0%)
First Day Return: -17.1%
Return from IPO: -86.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/09/2021 |
Offer Price | $17.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 6.5 |
Deal Size ($mm) | $111 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 04/29/2021 |
Offer Price | $17.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 6.5 |
Deal Size ($mm) | $111 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Morgan Stanley |
Jefferies |
more |
Company Data | |
---|---|
Headquarters | Oxford, United Kingdom |
Founded | 2016 |
Employees | 48 |
Website www.vaccitech.co.uk |